Status:
COMPLETED
Buprenorphine Dose Alteration Study - 1
Lead Sponsor:
University of Vermont
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-Related Disorders
Eligibility:
MALE
19-41 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to examine the effects in buprenorphine dose alterations in opioid dependent individuals being maintained on buprenorphine.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
December 1 1991
Trial Type :
INTERVENTIONAL
End Date :
July 1 2001
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000219
Start Date
December 1 1991
End Date
July 1 2001
Last Update
May 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Treatment Research Center
Burlington, Vermont, United States, 05401